The World Stroke Organization reports that “stroke has already reached epidemic proportions. Globally1 in 4 adults over the age of 25 will have a stroke in their lifetime. 12.2 million people worldwide will have their first stroke this year, and 6.5 million will die as a result.” Ischemic strokes are the most common type of stroke, with about 87% of all strokes being ischemic strokes.

This new volume addresses this epidemic by presenting detailed studies on ischemic injury, with emphasis on the molecular-level mechanisms and the role of signaling pathways in the body, their structure, and their mechanism of action. The book focuses on molecular pharmacology plans and explains the new areas of research on the discovery of therapeutic molecules that can be used for combating this life-threatening disease. The authors discuss stroke occurrence at different stages of life as well as sex-based differences in its treatment. They cover aspects of the clinical treatment and diagnosis of patients with cardiovascular events, including in-depth information on the prevention, evaluation, therapy selection, result projection, and long-term course of the disease in affected patients. They also detail the involvement of platelets, neurotransmitters, renin-angiotensin-aldosterone system, and vitamin D in ischemic injury.

The World Stroke Organization reports that “stroke has already reached epidemic proportions. Globally1 in 4 adults over the age of 25 will have a stroke in their lifetime. 12.2 million people worldwide will have their first stroke this year, and 6.5 million will die as a result.” Ischemic strokes are the most common type of stroke, with about 87% of all strokes being ischemic strokes.

This new volume addresses this epidemic by presenting detailed studies on ischemic injury, with emphasis on the molecular-level mechanisms and the role of signaling pathways in the body, their structure, and their mechanism of action. The book focuses on molecular pharmacology plans and explains the new areas of research on the discovery of therapeutic molecules that can be used for combating this life-threatening disease. The authors discuss stroke occurrence at different stages of life as well as sex-based differences in its treatment. They cover aspects of the clinical treatment and diagnosis of patients with cardiovascular events, including in-depth information on the prevention, evaluation, therapy selection, result projection, and long-term course of the disease in affected patients. They also detail the involvement of platelets, neurotransmitters, renin-angiotensin-aldosterone system, and vitamin D in ischemic injury.

The study of free radicals and their role in the development and progression of diseases has gained importance in recent decades, providing invaluable insights into the fundamental mechanisms of pathology. This new book describes the role of free radicals and their deleterious impact on human health, offering a deep understanding of the molecular and cellular processes involved in disease progression and helping to bridge the gap between scientific research and its applicability.

The chapters provide an examination of different diseases that are seen to be caused by harmful free radicals. The book also unravels the origin of free radicals and their intricate relationship with vital biomolecules. Through an examination of the diverse diseases affected by free radicals, the book uncovers their pivotal role in the pathology of conditions such as cancer, cardiovascular disorders, neurodegenerative diseases, diabetes, dyslipidemia, stroke, epilepsy, and others. The chapters also establish the delicate balance of the body’s antioxidant defense system, which plays a crucial role in mitigating the harmful effects of free radicals on human health.

The study of free radicals and their role in the development and progression of diseases has gained importance in recent decades, providing invaluable insights into the fundamental mechanisms of pathology. This new book describes the role of free radicals and their deleterious impact on human health, offering a deep understanding of the molecular and cellular processes involved in disease progression and helping to bridge the gap between scientific research and its applicability.

The chapters provide an examination of different diseases that are seen to be caused by harmful free radicals. The book also unravels the origin of free radicals and their intricate relationship with vital biomolecules. Through an examination of the diverse diseases affected by free radicals, the book uncovers their pivotal role in the pathology of conditions such as cancer, cardiovascular disorders, neurodegenerative diseases, diabetes, dyslipidemia, stroke, epilepsy, and others. The chapters also establish the delicate balance of the body’s antioxidant defense system, which plays a crucial role in mitigating the harmful effects of free radicals on human health.

The World Stroke Organization reports that “stroke has already reached epidemic proportions. Globally1 in 4 adults over the age of 25 will have a stroke in their lifetime. 12.2 million people worldwide will have their first stroke this year, and 6.5 million will die as a result.” Ischemic strokes are the most common type of stroke, with about 87% of all strokes being ischemic strokes.

This new volume addresses this epidemic by presenting detailed studies on ischemic injury, with emphasis on the molecular-level mechanisms and the role of signaling pathways in the body, their structure, and their mechanism of action. The book focuses on molecular pharmacology plans and explains the new areas of research on the discovery of therapeutic molecules that can be used for combating this life-threatening disease. The authors discuss stroke occurrence at different stages of life as well as sex-based differences in its treatment. They cover aspects of the clinical treatment and diagnosis of patients with cardiovascular events, including in-depth information on the prevention, evaluation, therapy selection, result projection, and long-term course of the disease in affected patients. They also detail the involvement of platelets, neurotransmitters, renin-angiotensin-aldosterone system, and vitamin D in ischemic injury.

The World Stroke Organization reports that “stroke has already reached epidemic proportions. Globally1 in 4 adults over the age of 25 will have a stroke in their lifetime. 12.2 million people worldwide will have their first stroke this year, and 6.5 million will die as a result.” Ischemic strokes are the most common type of stroke, with about 87% of all strokes being ischemic strokes.

This new volume addresses this epidemic by presenting detailed studies on ischemic injury, with emphasis on the molecular-level mechanisms and the role of signaling pathways in the body, their structure, and their mechanism of action. The book focuses on molecular pharmacology plans and explains the new areas of research on the discovery of therapeutic molecules that can be used for combating this life-threatening disease. The authors discuss stroke occurrence at different stages of life as well as sex-based differences in its treatment. They cover aspects of the clinical treatment and diagnosis of patients with cardiovascular events, including in-depth information on the prevention, evaluation, therapy selection, result projection, and long-term course of the disease in affected patients. They also detail the involvement of platelets, neurotransmitters, renin-angiotensin-aldosterone system, and vitamin D in ischemic injury.

The study of free radicals and their role in the development and progression of diseases has gained importance in recent decades, providing invaluable insights into the fundamental mechanisms of pathology. This new book describes the role of free radicals and their deleterious impact on human health, offering a deep understanding of the molecular and cellular processes involved in disease progression and helping to bridge the gap between scientific research and its applicability.

The chapters provide an examination of different diseases that are seen to be caused by harmful free radicals. The book also unravels the origin of free radicals and their intricate relationship with vital biomolecules. Through an examination of the diverse diseases affected by free radicals, the book uncovers their pivotal role in the pathology of conditions such as cancer, cardiovascular disorders, neurodegenerative diseases, diabetes, dyslipidemia, stroke, epilepsy, and others. The chapters also establish the delicate balance of the body’s antioxidant defense system, which plays a crucial role in mitigating the harmful effects of free radicals on human health.

The study of free radicals and their role in the development and progression of diseases has gained importance in recent decades, providing invaluable insights into the fundamental mechanisms of pathology. This new book describes the role of free radicals and their deleterious impact on human health, offering a deep understanding of the molecular and cellular processes involved in disease progression and helping to bridge the gap between scientific research and its applicability.

The chapters provide an examination of different diseases that are seen to be caused by harmful free radicals. The book also unravels the origin of free radicals and their intricate relationship with vital biomolecules. Through an examination of the diverse diseases affected by free radicals, the book uncovers their pivotal role in the pathology of conditions such as cancer, cardiovascular disorders, neurodegenerative diseases, diabetes, dyslipidemia, stroke, epilepsy, and others. The chapters also establish the delicate balance of the body’s antioxidant defense system, which plays a crucial role in mitigating the harmful effects of free radicals on human health.